Bio-Rad Laboratories Return On Tangible Equity 2010-2024 | BIO.B

Bio-Rad Laboratories return on tangible equity for the quarter ending June 30, 2024 was -17.62.

  • Bio-Rad Laboratories average return on tangible equity for 2023 was -4.29, a 85.9% increase from 2022.
  • Bio-Rad Laboratories average return on tangible equity for 2022 was -30.43, a 166.82% decline from 2021.
  • Bio-Rad Laboratories average return on tangible equity for 2021 was 45.54, a 8.77% decline from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.

Bio-Rad Laboratories Return On Tangible Equity 2010-2024 | BIO.B

  • Bio-Rad Laboratories average return on tangible equity for 2023 was -4.29, a 85.9% increase from 2022.
  • Bio-Rad Laboratories average return on tangible equity for 2022 was -30.43, a 166.82% decline from 2021.
  • Bio-Rad Laboratories average return on tangible equity for 2021 was 45.54, a 8.77% decline from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.